Get the Stockscreener App
0.3701
1.15%
-0.0043
After Hours:
.38
0.0099
+2.67%
Molecular Templates Inc stock is traded at $0.3701, with a volume of 524.91K.
It is down -1.15% in the last 24 hours and down -17.79% over the past month.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
See More
Previous Close:
$0.3744
Open:
$0.3792
24h Volume:
524.91K
Relative Volume:
0.05
Market Cap:
$2.44M
Revenue:
$23.48M
Net Income/Loss:
$-15.63M
P/E Ratio:
-0.0297
EPS:
-12.45
Net Cash Flow:
$-23.92M
1W Performance:
+10.38%
1M Performance:
-17.79%
6M Performance:
-68.09%
1Y Performance:
-92.34%
1-Day Range:
$0.36
$0.3897
1-Week Range:
$0.3326
$0.44
52-Week Range:
$0.295
$5.25
Molecular Templates Inc Stock (MTEM) Company Profile
Name
Molecular Templates Inc
Sector
Industry
Phone
512 896 1555
Address
9301 AMBERGLEN BLVD, AUSTIN, TX
Compare MTEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTEM
Molecular Templates Inc
|
0.3701 | 2.44M | 23.48M | -15.63M | -23.92M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-21 | Initiated | BofA Securities | Buy |
| Feb-01-21 | Initiated | UBS | Neutral |
| Sep-08-20 | Initiated | Jefferies | Buy |
| Mar-25-20 | Initiated | Stifel | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Apr-29-19 | Initiated | UBS | Buy |
| Dec-11-18 | Initiated | Oppenheimer | Outperform |
| Oct-08-18 | Initiated | Laidlaw | Buy |
View All
Molecular Templates Inc Stock (MTEM) Latest News
Stock Region Signal Report - substack.com
Molecular Templates faces delisting, seeks stockholder approval for dissolution - Investing.com
Molecular Templates faces delisting, seeks stockholder approval for dissolution By Investing.com - Investing.com Australia
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
BB Biotech AG's Strategic Acquisition in Molecular Templates Inc - GuruFocus.com
Bb Biotech sells $845,833 in Molecular Templates shares - Investing.com India
Bb Biotech sells $845,833 in Molecular Templates shares By Investing.com - Investing.com UK
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register
Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register
Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Stock Market Movers Today • Top Gainers & Losers - Benzinga
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM
U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn
Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Clairity Appoints Jeffrey R. Luber as CEO - citybiz
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN
In-vitro Transcription Templates Market to Witness Robust Growth at 19.53% CAGR by 2031 - WhaTech
Bitdeer Technologies Holding Co (NASDAQ: BTDR) Is The Number One Stock Currently Moving. - Stocks Register
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Global Leukemia Therapeutics Market Overview And Statistics For 2024-2033 - EIN News
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Wall Street-Heavily Traded - WDRB
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Biotech Alert: Searches spiking for these stocks today - TipRanks
why Molecular Templates Inc [MTEM] is a Good Choice for Investors After New Price Target of $18.00 - The DBT News
Closing Bell Recap: Molecular Templates Inc (MTEM) Ends at 0.39, Reflecting a -73.48 Downturn - The Dwinnex
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
MTEM stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
Molecular Templates Inc Stock (MTEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):